3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
3
OTHER_GOV
1
NIH
1
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
1
Interventions
Gemcitabine
15
Cisplatin
12
Radiotherapy
11
Metformin
8
Fluorouracil
8
Capecitabine
8
Paclitaxel
7
Oxaliplatin
7
Exercise
7
Indocyanine Green
6
Docetaxel
6
Cyclophosphamide
6
Control Groups
6
Surveys and Questionnaires
5
Standard of Care
5
Nivolumab
5
Letrozole
5
Irinotecan
5
pembrolizumab
4
durvalumab
4
Zoledronic Acid
4
Vinorelbine
4
Saline Solution
4
Preoperative Exercise
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Ifosfamide
4
Gefitinib
4
Drug Therapy
4
Carboplatin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
OTHER_GOV
×
Alendronate
×
Clear all
NCT00122356
2013-03-13
BATMAN
Barwon Health
Phase 3
Completed
303 enrolled